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Abstract
Background: Secreting interstitial cell (Leydig cell) tumors are rare. In adults, the clinical picture and steroid levels
are variable.
Case presentation: This paper presents a case of left testicular tumor, showing azoospermia with normal serum level
of total testosterone, collapsed FSH and LH, and high delta4 androstenedione. Histopathological investigation revealed
a Leydig cell tumor. TESE allowed spermatozoa extraction and freezing. Testicular histology found
hypospermatogenesis and germ-cell aplasia with interstitial fibrosis. Surgical resection of the tumor resulted in
normalization of gonadotropins and fall in serum delta4 androstenedione to subnormal levels in the postoperative
period confirming that the tumor was secreting delta4 androstenedione. It was hypothesized that high delta4
androstenedione resulted in intra tumoral 17 β-HSD overtaken by delta4 androstenedione or that 17 β-HSD activity in
the tumor was different from that of normal Leydig cells. Three months after surgery sperm analysis found a complete
recovery of spermatogenesis. A spontaneous pregnancy occurred 3 months after surgery and a girl was born.
Conclusions: In this case, the diagnosis of testicular Leydig cell tumor secreting delta4 androstenedione was made in
a context of azoospermia.
Keywords: Azoospermia, Infertility, Hormone secreting testicular tumor, Leydig cell tumor, delta4 androstenedione,
TESE
Résumé
Introduction: Les tumeurs testiculaires interstitielles (ou tumeurs testiculaires à cellules de Leydig) à expression
endocrine sont rares. Chez l’adulte le tableau clinique et le bilan hormonal sont variables.
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Présentation du cas: Cet article présente le cas d’une tumeur testiculaire gauche dans un contexte d’azoospermie.
Le bilan hormonal montre des gonadotrophines effondrées, une testostéronémie normale et une delta4
androstenedione augmentée. L’examen anatomopathologique a mis en évidence une tumeur à cellule de Leydig.
La TESE a permis l’extraction et la congélation de spermatozoïdes. L’histologie a retrouvé un aspect mixte
d’hypospermatogenèse diminuée incomplète et d’aplasie. Dans les suites de l’orchidectomie partielle gauche les
taux de gonadotrophines se sont normalisés ainsi que le taux de delta4 androstenedione. L’hypothèse
physiopathologique est que l’augmentation de la delta4 androstenedione résulte de la sursaturation de la 17 β-HSD
intra-tumoral ou que l’activité de la 17 β-HSD intra-tumoral est différente de celle dans les cellules de Leydig
normales. Trois mois après la chirurgie, le spermogramme a montré une normalisation des paramètres
spermatiques et une grossesse spontanée est survenue permettant la naissance d’une petite fille.
Conclusion: Dans ce cas clinique, le diagnostic de tumeur testiculaire à cellule de Leydig sécrétant de la delta4
androstenedione a été fait dans un contexte d’azoospermie.
Mots clés: Azoospermie, Infertilité, Tumeur testiculaire à sécrétion endocrine, Tumeur à cellules de Leydig,
delta4androstenedione, TESE
Background
Testicular neoplasms represent 1–1.5 % of all tumors in
men. Those derived from the interstitial cells of Leydig
are rare, constituting 1 % of testicular tumors. Hormone
secreting interstitial cell tumors are more unusual than
non-secreting interstitial tumors. In young males, the
tumor is usually associated with precocious puberty [1],
whereas in adults, the clinical picture and steroid levels
are variable [2–20]. This paper reports a case of testicu-
lar Leydig cell (interstitial cell) tumor secreting delta4
androstenedione in a patient with azoospermia.
Case presentation
A 44 year old man was referred to our clinic for second-
ary infertility; he had no medical or surgical history or
medical treatment. He was a butcher and married.
In 2009, he consulted another medical center for
primary infertility. His medical history included no tes-
ticular trauma, no inguino scrotal surgery, no crypt-
orchidism, no professional exposure, no tobacco, no
alcohol, or drug consumption. Semen analysis is sum-
merized in Table 1.
Serum level of total testosterone was 5.03 mg/L, FSH
1.0 IU/L. Spermoculture found ureaplasma urealyticum.
Scrotal ultrasonography (Table 2) revealed:
Right testis: Normal in size and echotexture, without a
focal lesion; normal epididymides; no varicocele;
normal vasculature at Doppler examination.
Left testis: a left hypoechoic polylobulated
intratesticular mass measuring 30 × 16 mm, including
numerous septa, and showing high vasculature at
Doppler examination.
At that time, ofloxacine 200 mg twice per day during
15 days was prescribed. A spontaneaous pregnancy oc-
curred in 2009 and a boy was born in 2010 (3800 g). Be-
tween 2009–2014 the patient had no follow-up for this
mass.
In 2014 the patient consulted a doctor in our clinic as
he wished to have another child. Semen analyses showed
strict azoospermia with normal volume (Table 1).
Physical examination showed a normal andrological
development, testes were present in the scrotum, a
slightly indurated mass could be felt in the upper pole of
the left testis. Right testis was hypotrophic, seminal con-
ducts were felt. There was neither gynecomastia nor any
sign of hypercortisolism.
Scrotal ultrasonography found (Table 2) a hypotrophic
right testicle (8.5 mL), but a hypoechoic lobulated mass
was visible in the left testicle with heterogeneous echo-
texture, measuring 32 × 31 × 23 mm, with slight vascu-
lature at Doppler examination.
Serum analyses are described in Table 3. Total tes-
tosterone was measured by RIA using the Coat-A-
Count Kit (Siemens Diagnostics, Inc., Los Angeles,
CA, USA). The assay’s limit of quantification was
0.14 nmol/L (0.04ng/mL) and the interassay CV was
between 5.9 and 11.0 % for a range of concentra-
tions between 0.76 and 13ng/mL. The FSH, LH, and
estradiol were measured using chemiluminescent,
two-site immunoassays on a multiparameter analyzer
Table 1 Semen analyses
2009 Under 2014 Under 3 months
Volume (mL) 4.2 4.3 3.5
Spermatozoa (106/ejaculate) 0.78 0 259
Progressive motility (%) 19 0 60
Typical spermatozoa (%) NF 0 33
NF not feasible
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(Architect; Abbott Laboratories). Delta4 androstene-
dione was measured in duplicate by radioimmuno-
assay using a kit provided by Beckman Coulter
Immunotech. The percentage of testosterone cross-
reactivity was 0.5 % with androstenedione and
0.02 % with estradiol.
A marked increase in androstenedione levels and sup-
pressed gonadotropin levels were found which are likely
to contribute to the failure of spermatogenesis. Normal
Dehydroepiandrosterone Sulfate argues against adrenal
hyperandrogenism.
Abdomen and Thorax Computed Tomography (CT)
imaging were normal (no adrenal gland abnormality and
no secondary lesions).
The committee on tumoral diseases agreed on the de-
cision to perform a testis-sparing surgery with extem-
poraneous histological examination. We decided to
perform a testicular sperm extraction (TESE) at the
same time. TESE allowed spermatozoa extraction with
freezing.
Surgical resection of the tumor (Fig. 1) allowed a
tumor of 35 × 30 × 17 mm to be removed.
Immunostaining was performed on an automated
immunostainer (Benchmark, Ventana, France) with anti-
bodies to Inhibin A (Ventana, prediluted, pretreatment:
EDTA pH 7.8 for 60 min) and to SALL4 (Sigma, Dilu-
tion: 1/1500, pretreatment: EDTA pH 7.8 for 60 min).
All tumor cells were diffusely and strongly stained with
antibody to Inhibin A corresponding to Leydig cell
tumor and were completely negative to antibodies to
SALL4 showing that there was no germ cell contingent
(Figs. 2, 3 and 4).
The testicular histology found hypospermatogenesis
and germ-cell aplasia with interstitial fibrosis (Fig. 5).
Surgical resection of the tumor (Fig. 1) resulted in
normalization of gonadotropins and fall in serum delta4
androstenedione to subnormal levels in the postopera-
tive period confirming that the tumor was secreting
delta4 androstenedione (Table 4).
We hypothesized that high delta4 androstenedione re-
sulted in intra tumoral 17 β-HSD overtaken by a delta4
androstenedione excess or that 17 betaHSD activity in
the tumor was different from that of normal Leydig cells
(Fig. 6).
Scrotal ultrasonography 3 months after surgery de-
scribed a normal right testis which had increased in size
(volume 15 mL) and a left testis with a rearranged aspect
secondary to surgery (Table 2).
Three months after surgery semen analyses showed a
complete recovery of spermatogenesis (Table 1). A spon-
taneous pregnancy occurred, 3 months after surgery and
a girl was born in 2015 (3450 g).
Discussion
To the authors’ knowledge only one case of androstene-
dione secreting testicular Leydig cell tumors associated
Table 2 Scrotal ultrasonography




Normal in size and echotexture, without focal lesion; normal
epididymides; no varicocele; normal vasculature at Doppler
examination





Presence of a 30 × 16 mm polylobulated intratesticular mass,
with low echogenicity, numerous septa, and high vasculature
at Doppler examination
Low echogenicity intratesticular lobulated mass, with
heterogeneous echotexture, low echogenicity, measuring







Table 3 Hormonal results in 2014
Normal range Patient
LH IU/L 0.60–12 <0.1
Total testosterone ng / mL 2.30–6.7 4.61
Testosterone/SBP 28–78 46.19
Free testosterone pmol/L 188-444 311.04
FSH IU/L 1.2.–7.8 0.2
Inhibin B pg/mL 92–316 54
Delta4 androstenedione ng/mL 0.4–1.5 10.40
17 OH progesterone ng/mL 0.5–2.5 1.07
Dehydroepiandrosterone Sulfate μmol/L 1.7–12.8 6.0
Estradiol pg/mL 9–62 26
LDH IU/L 135–225 214
Human CG IU/L <2.5 < 2
Alfa foeto protein μg/L < 10 1
Cortisol (8 AM) μg / 100 mL 9–22 9.8








μg / 100 mL : microgram/100 milliliter
Prasivoravong et al. Basic and Clinical Andrology  (2016) 26:14 Page 3 of 8
with azoospermia has been reported previously [2]. In
that case, serum levels of testosterone, dihydrotestoster-
one, 5α-androstane-3α,17βdiol and oestradiol were nor-
mal and oestrone was moderately increased. In contrast
androstenedione was extremely elevated. Testosterone
levels in the spermatic vein were decreased indicating a
partial deficiency of 17β hydroxysteroid dehydrogenase
in the tumoral tissue. Twenty-eight months after sur-
gery, all sex steroids including androstenedione were
normal.
Fig. 1 Surgical resection of the tumor. Tumor of 35 × 30 × 17 mm
Fig. 2 Photo of the tumor at low magnification (X50). Nodular and well limited tumor composed of sheets of eosinophilic cells with Hematoxylin
Eosin and Saffron (HES) stain
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Fig. 3 Photo of the tumor at high magnification (X200). Tumor cells are large with an abundant eosinophilic cytoplasm and round regular nuclei
with small nucleoli, according with Leydig cells. Hematoxylin Eosin and Saffron (HES) stain
Fig. 4 Photo of the tumor at high magnification (X400). Tumors cells were diffusely stained with antibody to inhibin A(immunoperoxydase). All
tumor cells present a diffuse and strong cytoplasmic staining
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In the present case, total suppression of LH levels and
almost complete suppression of FSH levels were associ-
ated with azoospermia, despite intratesticular testoster-
one secretion by the tumor, and azoospermia proved to
be fully reversible within less than three months after
tumor removal and normalization of hormone levels,
which shows that normal secretion of gonadotropins,
plays a major role in maintaining spermatogenesis. This
appears to be in agreement with other (rare) reports
of patients with Leydig cell tumors and reversible
azoospermia, who did not suffer from other testicular
disorders. Interestingly, in these previous reports, the
patients were also found to have testosterone secreting
Leydig cell tumors with undetectable [15] or markedly
reduced [12] gonadotropin levels, which suggests that
intratesticular secretion of testosterone by the tumor is
not sufficient to prevent azoospermia in spite of marked
suppression of LH and FSH secretion. The present paper
shows that even with collapsed gonadotropin levels TESE
allowed extraction of spermatozoa.
Fig. 5 Photo of the testicular biopsy at high magnification (X100). Histopathological micrograph with hematoxylin-eosin-green FCF stain. The
testicular biopsy consists of tubules with hypospermatogenesis (white arrows) mixed with aplasia (black arrows)
Table 4 Selected hormonal values before and after surgery in 2014
Normal range 1 month before surgery 1 day post-operative 2 months post-operative
LH (IU/L) 0.6–12.0 0.1 <0.1 1.6
Total Testosteronea (ng/mL) 2.3–6.7 4.61 0.37 2.28
SBP (nmol/L) 12.5–42.2 34.6 ND 30.7
Delta4 androstenedione (ng/mL) 0.4–1.5 10.4 1.08 0.43
FSH (IU/L) 1.2–7.8 0.2 0.2 2.7






aTo convert serum testosterone values from ng/mL into system international (SI) units (nmol/L), multiply by 3.47
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Conclusions
Hormone secreting interstitial cell tumors are rare and
have variable clinical presentations. In the case pre-
sented in this paper, the diagnosis was made in a context
of azoospermia. Few months after tumorectomy, sex
steroid levels and spermatogenesis returned to normal
and a spontaneous pregnancy occurred.
Abbreviations
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